GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vistin Pharma ASA (OSL:VISTN) » Definitions » Cyclically Adjusted Revenue per Share

Vistin Pharma ASA (OSL:VISTN) Cyclically Adjusted Revenue per Share : kr10.14 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Vistin Pharma ASA Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Vistin Pharma ASA's adjusted revenue per share for the three months ended in Mar. 2025 was kr2.594. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr10.14 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-06-23), Vistin Pharma ASA's current stock price is kr24.10. Vistin Pharma ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was kr10.14. Vistin Pharma ASA's Cyclically Adjusted PS Ratio of today is 2.38.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Vistin Pharma ASA was 2.80. The lowest was 2.13. And the median was 2.39.


Vistin Pharma ASA Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Vistin Pharma ASA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vistin Pharma ASA Cyclically Adjusted Revenue per Share Chart

Vistin Pharma ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 10.03

Vistin Pharma ASA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 9.96 9.95 10.03 10.14

Competitive Comparison of Vistin Pharma ASA's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Vistin Pharma ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vistin Pharma ASA's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vistin Pharma ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Vistin Pharma ASA's Cyclically Adjusted PS Ratio falls into.


;
;

Vistin Pharma ASA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vistin Pharma ASA's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.594/136.1000*136.1000
=2.594

Current CPI (Mar. 2025) = 136.1000.

Vistin Pharma ASA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 1.736 100.100 2.360
201509 5.301 100.600 7.172
201512 0.000 100.900 0.000
201603 5.960 102.500 7.914
201606 3.140 103.800 4.117
201609 2.192 104.200 2.863
201612 1.919 104.400 2.502
201703 2.560 105.000 3.318
201706 2.689 105.800 3.459
201709 2.781 105.900 3.574
201712 2.437 106.100 3.126
201803 3.062 107.300 3.884
201806 1.551 108.500 1.946
201809 1.141 109.500 1.418
201812 0.753 109.800 0.933
201903 0.845 110.400 1.042
201906 1.378 110.600 1.696
201909 1.534 111.100 1.879
201912 1.259 111.300 1.540
202003 1.385 111.200 1.695
202006 1.647 112.100 2.000
202009 1.242 112.900 1.497
202012 1.436 112.900 1.731
202103 1.597 114.600 1.897
202106 1.507 115.300 1.779
202109 1.417 117.500 1.641
202112 1.698 118.900 1.944
202203 0.749 119.800 0.851
202206 1.556 122.600 1.727
202209 2.068 125.600 2.241
202212 2.114 125.900 2.285
202303 2.276 127.600 2.428
202306 2.407 130.400 2.512
202309 2.705 129.800 2.836
202312 2.497 131.900 2.577
202403 2.343 132.600 2.405
202406 2.392 133.800 2.433
202409 2.387 133.700 2.430
202412 2.564 134.800 2.589
202503 2.594 136.100 2.594

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Vistin Pharma ASA  (OSL:VISTN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Vistin Pharma ASA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=24.10/10.14
=2.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Vistin Pharma ASA was 2.80. The lowest was 2.13. And the median was 2.39.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Vistin Pharma ASA Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Vistin Pharma ASA's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vistin Pharma ASA Business Description

Industry
Traded in Other Exchanges
Address
Ostensjoveien 27, P.O. Box 6735 Etterstad, Oslo, NOR, 0661
Vistin Pharma ASA is a Norway based pharmaceutical company. It is principally engaged in the business activity of producing active pharmaceutical ingredients (APIs) and solid dosage forms for the pharmaceutical industry. The company has two business segments namely Pharmaceuticals and Energy Trading. The group has operations in Norway, Germany, Switzerland, Great Britain, Algeria and other countries.

Vistin Pharma ASA Headlines

No Headlines